Traws Pharma, Inc. Capital Expenditures
Traws Pharma, Inc. (TRAW) reported Capital Expenditures of $14.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-03-31
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $0.00.
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $0.00.
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-09-30 was $0.00.
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was -$1.00K.
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $14.00K.
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $15.00K, a 72.73% decline from fiscal 2019.
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $55.00K.
- Traws Pharma, Inc. payments to acquire property, plant, and equipment for fiscal 2014 was $228.00K, a 62.56% decline from fiscal 2013.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $14.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $14.00K 10-Q · filed 2024-11-14 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $15.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $15.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $15.00K 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $55.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $56.00K 10-Q · filed 2020-11-16 | |||
| 2014-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $6.00K derived: sum of 2 quarters · filed 2016-03-28 | $156.00K derived: sum of 3 quarters · filed 2016-03-28 | $228.00K 10-K · filed 2016-03-28 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $150.00K derived: sum of 2 quarters · filed 2015-11-12 | $222.00K 10-Q · filed 2015-11-12 | $316.00K derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $222.00K 10-Q · filed 2015-08-13 | $316.00K derived: sum of 3 quarters · filed 2015-08-13 | $358.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $72.00K 10-Q · filed 2015-05-15 | $166.00K derived: sum of 2 quarters · filed 2015-05-15 | $208.00K derived: sum of 3 quarters · filed 2015-05-15 | $397.00K derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $136.00K derived: sum of 2 quarters · filed 2015-03-30 | $325.00K derived: sum of 3 quarters · filed 2015-03-30 | $609.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $231.00K derived: sum of 2 quarters · filed 2014-11-14 | $515.00K 10-Q · filed 2014-11-14 | $663.00K derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | $189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $473.00K 10-Q · filed 2014-08-14 | $621.00K derived: sum of 3 quarters · filed 2015-03-30 | $746.00K derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | $284.00K 10-Q · filed 2014-05-15 | $432.00K derived: sum of 2 quarters · filed 2015-03-30 | $557.00K derived: sum of 3 quarters · filed 2015-03-30 | |
| 2012-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $273.00K derived: sum of 2 quarters · filed 2015-03-30 | $279.00K 10-K · filed 2015-03-30 | |
| 2012-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $131.00K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $6.00K 10-Q · filed 2013-09-06 | |||
| 2011-12-31 | $256.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |